Is Apimeds (APUS) the Most Undervalued Small-Cap Biotech?
Apimeds Pharmaceuticals US Inc. (NYSE:APUS) is a clinical-stage biopharmaceutical company built on a mission to transform pain management…
DiaMedica (DMAC) Advances Preeclampsia Trial as Cash Runway Extends to 2027
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for serious diseases driven…
YD Bio (YDES) Surges After $13.2M Financing
YD Bio Limited (NASDAQ:YDES) is a biotechnology company built on a dual scientific foundation: advancing DNA methylation–based cancer…
Why Analysts Believe Oscar Health (OSCR) Could Become a $12B-Plus Digital Insurance Powerhouse
Oscar Health Inc. (NASDAQ:OSCR) is a technology-driven health insurance company founded with the mission of making healthcare simple,…
Twist Bioscience (TWST) Cash Position Hits $232.4M—Is It Enough to Fund 2026 Expansion?
Twist Bioscience (NASDAQ:TWST) is a synthetic biology and biotechnology company built on the vision of transforming how DNA…
Anavex (AVXL) Faces Major Setback as CHMP Issues Negative Vote on Alzheimer’s Drug
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for central nervous…
Kura Oncology (KURA) Skyrockets After FDA Approves KOMZIFTI for NPM1-Mutated AML
Kura Oncology (NASDAQ:KURA) is a clinical-stage biopharmaceutical company built on the vision of developing precision medicines that target…
Korro Bio (KRRO) Surges After Human RNA Editing Success in AATD Trial
Korro Bio Inc. (NASDAQ:KRRO) is a clinical-stage biopharmaceutical company pioneering a new generation of genetic medicines through precise,…
Mersana Therapeutics (MRSN) Surges After $285M Acquisition Deal With Day One Biopharmaceuticals
Mersana Therapeutics (NASDAQ:MRSN) is a clinical-stage biopharmaceutical company shaped by a long-standing commitment to expanding what is possible…
Cidara Therapeutics (CDTX) Skyrockets 108.9% as Merck Acquisition Hits $221.50 Per Share
Cidara Therapeutics (NASDAQ:CDTX) is a clinical-stage biotechnology company founded with the mission of transforming the prevention and treatment…
Trevi Therapeutics (TRVI) Surges as Cash Runway Extends to 2028 After Reporting $194.9M Assets
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for some of the most…
Greenwich LifeSciences (GLSI) Reports 100% Survival Data and Heavy Insider Buying!
Greenwich LifeSciences Inc. (NASDAQ:GLSI) is a clinical-stage biopharmaceutical company committed to developing innovative immunotherapy solutions for one of…
Abeona Therapeutics (ABEO) Slashes Quarterly Loss by 83%
Abeona Therapeutics Inc. (NASDAQ:ABEO) is a clinical-stage and now commercial biopharmaceutical company pioneering the development of transformative cell…
Why Viking Therapeutics (VKTX) Could Dominate the $100B Obesity Drug Market by 2030
Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinical-stage biopharmaceutical company headquartered in San Diego, California, focused on the discovery…
CorMedix (CRMD) Surges After Posting $108.6M Net Income in Q3 2025
CorMedix Inc. (NASDAQ:CRMD) is a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, dedicated to developing and commercializing…
UnitedHealthcare (UNH) Hits $87.1 B Revenue in Q3
UnitedHealth Group Incorporated (NYSE:UNH) is the largest healthcare company in the world by revenue, a Fortune 5 powerhouse…
Why Sensus Healthcare (SRTS) Could Be a Hidden Med-Tech Gem in 2026
Sensus Healthcare Inc. (NASDAQ:SRTS) is a pioneering medical device company that specializes in the development and commercialization of…
Why Alpha Cognition (ACOG) Could Be the Next Big Alzheimer’s Breakthrough Stock
Alpha Cognition Inc. (NASDAQ:ACOG) is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for neurodegenerative…